ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

PREVENTion of Clot in Orthopaedic Trauma

ClinicalTrials.gov ID: NCT02984384

Public ClinicalTrials.gov record NCT02984384. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 6:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PREVENTion of Clot in Orthopaedic Trauma (PREVENT CLOT): A Randomized Pragmatic Trial Comparing the Complications and Safety of Blood Clot Prevention Medicines Used in Orthopaedic Trauma Patients

Study identification

NCT ID
NCT02984384
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Major Extremity Trauma Research Consortium
Other
Enrollment
12,424 participants

Conditions and interventions

Interventions

  • Acetylsalicylic acid Drug
  • Low Molecular Weight Heparin (LMWH) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 23, 2017
Primary completion
Feb 17, 2022
Completion
Feb 17, 2022
Last update posted
May 13, 2024

2017 – 2022

United States locations

U.S. sites
19
U.S. states
16
U.S. cities
19
Facility City State ZIP Site status
University of Arizona Tucson Arizona 85724
University of Miami Ryder Trauma Center Miami Florida 33136
Methodist Hospital Indianapolis Indiana 46202
University of Maryland R Adams Cowley Shock Trauma Center Baltimore Maryland 21201
Massachusetts General Hospital Boston Massachusetts 02114
University of Mississippi Medical Center Jackson Mississippi 39216
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756
Carolinas Medical Center Charlotte North Carolina 28204
Wake Forest University Baptist Medical Center Winston-Salem North Carolina 27157
MetroHealth Medical Center Cleveland Ohio 44109
Allegheny General Hospital Pittsburgh Pennsylvania 15212
Rhode Island Hospital, Brown University Providence Rhode Island 02903
University of Tennessee, RegionOne Medical Center Memphis Tennessee 38103
Vanderbilt Medical Center Nashville Tennessee 37232
University of Texas Health Science Center at Houston Houston Texas 77030
San Antonio Military Medical Center San Antonio Texas 78219
Inova Fairfax Hospital Falls Church Virginia 22042
Harborview Medical Center Seattle Washington 98104
University of Wisconsin Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02984384, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2024 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02984384 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →